Skip to content

Insight, China's Pharmaceutical Industry

Fineline Insights, Pharma Clarity

  • Home
  • About US
  • Bioinsight
  • Policy Hub
  • Deals Book
  • Privacy Policy
  • Contact US

Header Toggle Sidebar

This is an example widget to show how the Header Toggle Sidebar looks by default. You can add custom widgets from the widgets in the admin.

Xtalpi

    • Home
    • Xtalpi
    • Page 3
Company Deals

XtalPi Partners with CK Life Sciences to Develop AI Cancer Vaccine Platform

Fineline Cube Nov 25, 2022

Sino-US artificial intelligence (AI) firm XtalPi Inc. has struck a partnership with China-based CK Life...

Company Deals

XtalPi Partners with Janssen to Accelerate Drug Discovery

Fineline Cube Oct 31, 2022

China-based XtalPi, Inc. has announced a research collaboration with Janssen Pharmaceutica NV, one of the...

Company Deals

META Pharmaceuticals Secures $14.8 Million to Advance Immuno-Metabolism Drug Development

Fineline Cube Jun 13, 2022

Shenzhen-based META Pharmaceuticals Inc., a developer of immuno-metabolism targeted small molecules, has reportedly raised RMB...

Posts pagination

1 2 3

Recent updates

  • Henlius Triple Combo Gets NMPA Nod for Advanced Solid Tumor Trials
  • Hengrui’s HRS-5346 Lp(a) Inhibitor Gets China Breakthrough Therapy Designation in $1.97B Merck Deal
  • IVD Medical Launches Nipah Virus Detection Kit with AI Early Warning Platform
  • Betta Pharmaceuticals’ BPI-572270 RAS Inhibitor Gets NMPA Nod for Solid Tumor Trials
  • Nanjing Leads Biolabs Secures FDA Fast Track for LBL-034 in Multiple Myeloma
Special Report 2025 Q1: U.S. Targets Chinese Pharma with 200% Tariffs—Will the Global Drug Market Collapse?

Category

  • Company
  • Deals
  • Digital
  • Drug
  • General/Other
  • Hospital
  • Legal / IP
  • Medical Device
  • Others
  • Policy / Regulatory
  • R&D

You Missed

Company Drug

Henlius Triple Combo Gets NMPA Nod for Advanced Solid Tumor Trials

Company Drug

Hengrui’s HRS-5346 Lp(a) Inhibitor Gets China Breakthrough Therapy Designation in $1.97B Merck Deal

Company Deals Medical Device

IVD Medical Launches Nipah Virus Detection Kit with AI Early Warning Platform

Company Drug

Betta Pharmaceuticals’ BPI-572270 RAS Inhibitor Gets NMPA Nod for Solid Tumor Trials

Insight, China's Pharmaceutical Industry

Fineline Insights, Pharma Clarity

Copyright © 2025 | Fineline Information & Technology | BlogData by Themeansar.